World Asset Management Inc Sells 841 Shares of Clorox Co (CLX)

Share on StockTwits

World Asset Management Inc trimmed its holdings in shares of Clorox Co (NYSE:CLX) by 8.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,425 shares of the company’s stock after selling 841 shares during the quarter. World Asset Management Inc’s holdings in Clorox were worth $1,453,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Meeder Asset Management Inc. bought a new position in shares of Clorox in the fourth quarter worth approximately $26,000. City Holding Co. boosted its position in shares of Clorox by 150.0% in the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock worth $39,000 after purchasing an additional 150 shares during the period. G&S Capital LLC boosted its position in shares of Clorox by 46.4% in the fourth quarter. G&S Capital LLC now owns 262 shares of the company’s stock worth $40,000 after purchasing an additional 83 shares during the period. Ipswich Investment Management Co. Inc. bought a new position in shares of Clorox in the fourth quarter worth approximately $73,000. Finally, Csenge Advisory Group bought a new position in shares of Clorox in the third quarter worth approximately $100,000. Institutional investors own 77.66% of the company’s stock.

In related news, SVP Michael R. Costello sold 6,882 shares of the company’s stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $160.08, for a total transaction of $1,101,670.56. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 10,585 shares of the company’s stock in a transaction on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the sale, the senior vice president now directly owns 17,994 shares in the company, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 256,728 shares of company stock worth $41,973,324. 1.40% of the stock is owned by insiders.

A number of research firms have weighed in on CLX. Zacks Investment Research reiterated a “sell” rating on shares of Clorox in a research report on Monday, November 12th. Wells Fargo & Co upped their price target on shares of Clorox from $145.00 to $160.00 and gave the stock a “market perform” rating in a research report on Wednesday, December 12th. They noted that the move was a valuation call. BMO Capital Markets set a $175.00 price target on shares of Clorox and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Barclays restated a “hold” rating and set a $142.00 target price on shares of Clorox in a research report on Wednesday, February 6th. Finally, Bank of America restated a “neutral” rating and set a $170.00 target price (up previously from $150.00) on shares of Clorox in a research report on Thursday, December 6th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $149.08.

Shares of NYSE:CLX opened at $155.66 on Monday. The company has a debt-to-equity ratio of 3.08, a current ratio of 1.15 and a quick ratio of 0.65. Clorox Co has a fifty-two week low of $113.57 and a fifty-two week high of $167.70. The firm has a market cap of $19.95 billion, a P/E ratio of 24.87, a P/E/G ratio of 3.86 and a beta of 0.29.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.08. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. Clorox’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.77 earnings per share. Research analysts anticipate that Clorox Co will post 6.33 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, February 8th. Investors of record on Wednesday, January 23rd were paid a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date was Tuesday, January 22nd. Clorox’s payout ratio is 61.34%.

TRADEMARK VIOLATION WARNING: “World Asset Management Inc Sells 841 Shares of Clorox Co (CLX)” was originally posted by Fairfield Current and is owned by of Fairfield Current. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.fairfieldcurrent.com/news/2019/02/11/world-asset-management-inc-sells-841-shares-of-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply